See more : TC Biopharm (Holdings) Plc (TCBPW) Income Statement Analysis – Financial Results
Complete financial analysis of Sandbridge X2 Corp. (SBII-UN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sandbridge X2 Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Duksung Co., Ltd. (004830.KS) Income Statement Analysis – Financial Results
- China Ruyi Holdings Limited (0136.HK) Income Statement Analysis – Financial Results
- Washington Hotel Corporation (4691.T) Income Statement Analysis – Financial Results
- AR advanced technology, Inc. (5578.T) Income Statement Analysis – Financial Results
- Merkur PrivatBank KgaA (MBK.DE) Income Statement Analysis – Financial Results
Sandbridge X2 Corp. (SBII-UN)
About Sandbridge X2 Corp.
Sandbridge X2 Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
Metric | 2021 |
---|---|
Revenue | 0.00 |
Cost of Revenue | 0.00 |
Gross Profit | 0.00 |
Gross Profit Ratio | 0.00% |
Research & Development | 0.00 |
General & Administrative | 2.49M |
Selling & Marketing | 0.00 |
SG&A | 2.49M |
Other Expenses | 0.00 |
Operating Expenses | 2.49M |
Cost & Expenses | 2.49M |
Interest Income | 3.04K |
Interest Expense | -376.96K |
Depreciation & Amortization | 2.86M |
EBITDA | 372.70K |
EBITDA Ratio | 0.00% |
Operating Income | -2.49M |
Operating Income Ratio | 0.00% |
Total Other Income/Expenses | 3.24M |
Income Before Tax | 749.66K |
Income Before Tax Ratio | 0.00% |
Income Tax Expense | -2.86M |
Net Income | 3.61M |
Net Income Ratio | 0.00% |
EPS | 0.14 |
EPS Diluted | 0.14 |
Weighted Avg Shares Out | 25.90M |
Weighted Avg Shares Out (Dil) | 25.90M |
Source: https://incomestatements.info
Category: Stock Reports